I tend to agree (and hope) with Trent's line of thinking. I am not certain a private placement would have gone down to well. At least this way they can say everyone had a chance.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025